Making the Invisible, Visible - UCV
Making the Invisible, Visible – Airborne Particle Monitoring and Control Systems Integration with Ventilation Canopies for Improved Infection Control and Higher Patient and Staff Safety
For many years, we have been able to achieve a high standard of hygiene in hospitals and operating theatres in UK and elsewhere in Western Europe. However, intensifying cost pressures, the shortage of skilled surgical staff and the increasing frequency of multidrug-resistant germs (MRSA) are now causing problems. Existing standards will therefore no longer be adequate in the future, and the risk of patients being exposed to infection during surgical operations will rise.
Learning Outcomes:
- How to design and implement custom measures and renewed processes based on continuous airborne particle monitoring during surgical procedures, especially orthopaedic
- Role of visual indication of airborne particle load during operations for staff training and lasting behavioural changes in order to achieve higher patient and staff safety
- How to cut energy costs and noise load through automatic, continuous air flow adjustments based on real-time monitoring of airborne particles.
Airborne particles are a critical factor which have a direct effect on the hygienic standards of the modern operating theatre and their significance is easy to explain: The fewer particles in the air, the fewer germs can be deposited on these particles, any particle above >0.5 microns are able to support viable bacteria which can lead to infection at the wound site.
The traditional measurement provided by a single annual test is simply not sufficient, once calibrated it is “assumed” that the performance of the UCV will not differ drastically over a 12-month term but there are many factors which can directly affect the performance.
Continuous, real-time monitoring – with visual indicators- allows for implantation of improved procedures, risk minimisation and cost efficiencies.
Recent articles
Innovative Partnership between Brandon Medical, UK, and Device Technologies, Australia,
Innovative Partnership between Brandon Medical, UK, and Device Technologies, Australia, Set to Transform Healthcare in the Asia Pacific Region
Medica 2023
Medica 2023: Exploring Healthcare Innovation and Patient Care Advancements
Brandon Medical attends Arab Health H2 H11
Brandon Medical attends Arab Health H2 H11